Skip to content

A Study of LY4175408 in Participants With Advanced or Metastatic Solid Tumors.

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-521916-20-00
Acronym
J6D-MC-JSDA
Enrollment
80
Registered
2025-09-29
Start date
2025-10-24
Completion date
Unknown
Last updated
2025-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

None listed

Sponsors

Eli Lilly & Co.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

France, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026